A股異動 | 通裕重工(300185.SZ)漲4% 公司產品通過工信部製造業單項冠軍產品複核
格隆匯12月21日丨通裕重工(300185.SZ)股價快速拉昇,現報3.75元,漲幅4.17%,總市值146.13億。公司於近日收到《工業和信息化部中國工業經濟聯合會關於印發第六批製造業單項冠軍及通過複核的第三批製造業單項冠軍企業(產品)名單的通知》,公司風力發電機主軸產品作為第三批製造業單項冠軍產品通過了複核。本次通過複核,是對公司風力發電機主軸產品的質量、技術及市場競爭力的充分認可,進一步提升了公司在風電產品細分領域的品牌形象。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.